| (V524) |
The expression of macrophage migration inhibitory factor (MIF) is enhanced in acute coronary syndrome and correlates with the inflammatory response in patients with symptomatic coronary artery disease |
|
I. I. Müller, H. Schönleber, K. A. L. Müller, M. Schneider, B. Bigalke, M. Gawaz, T. Geisler (Tübingen) |
| (V525) |
Monocyte subsets in cardiac allograft vasculopathy and correlation with disease severity |
|
G. Maye, A. Limbourg, C. Bara, T. Limbourg, A. Haverich, F. Limbourg (Hannover, Ludwigshafen) |
| (V526) |
Die therapeutische Aktivierung regulatorischer T-Zellen verbessert die Wundheilung nach Myokardinfarkt |
|
U. Hofmann, J. Weirather, N. Beyersdorf, G. Ertl, T. Kerkau, S. Frantz (Würzburg) |
| (V527) |
“Macrophage migration inhibitory factor” (MIF) is carried by platelets of patients with stable and unstable angina pectoris and its amount correlates with the stability of coronary artery disease |
|
I. I. Müller, A. Karathanos, M. Schneider, K. A. L. Müller, H. Schönleber, P. Seizer, M. Gawaz, T. Geisler (Tübingen) |
| (V528) |
Frequency and functional characterization of Regulatory T cell subsets in patients with coronary artery disease. |
|
L. K. Hasib, K. Backteman, L. Jonasson, J. Ernerudh (Linköping, SE) |
| (V529) |
Free fatty acids alter inhibition of platelet function by acetylsalicylic acid in patients with diabetes mellitus |
|
C. Ledwoch, T. Hohlfeld, N. Schloot, B. Nowotny, M. Roden (Düsseldorf) |